Literature DB >> 20581434

Medulloblastoma: a disease with disorganized developmental signaling cascades.

Ninib Baryawno1, Baldur Sveinbjörnsson, Per Kogner, John Inge Johnsen.   

Abstract

Sonic Hedgehog, Wnt and PI3K/Akt are three developmental signalling cascades that all have crucial functions during normal brain development. The activation of one or several of these cascades is also found in the majority of medulloblastoma, the most common pediatric malignant tumor of the central nervous system. The aberrant expression of key molecules in developmental signalling pathways or inhibition of the activity of proteins regulating the activity of these cascades is important for medulloblastoma proliferation and survival. These developmental signal transduction pathways transfer signals from the cell membrane to transcription factors in the nucleus, resulting in an altered gene expression. Molecular cross-talks between these developmental cascades have been described in several cancers and may have important functions in tumorigenesis. One common kinase for these three signalling cascades is GSK-3β, which seems to be the glue that links these cascades together. Medulloblastoma cells display many characteristics that are interrelated to the progenitor cells of the embryonic brain where these developmental cascades are essential for proper development. Hence, understanding the relationship between normal brain development and medulloblastoma molecular pathogenesis is essential for more efficient, less toxic tailored therapies to be developed and implemented.
© 2010 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581434     DOI: 10.4161/cc.9.13.12170

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

Review 1.  Targeted treatment for sonic hedgehog-dependent medulloblastoma.

Authors:  Mark W Kieran
Journal:  Neuro Oncol       Date:  2014-06-20       Impact factor: 12.300

2.  Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.

Authors:  Flora Cimmino; Maria Nunzia Scoppettuolo; Marianeve Carotenuto; Pasqualino De Antonellis; Valeria Di Dato; Gennaro De Vita; Massimo Zollo
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

Review 3.  A contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.

Authors:  N Ceren Sümer-Turanlıgil; Emel Öykü Cetin; Yiğit Uyanıkgil
Journal:  Childs Nerv Syst       Date:  2013-01-06       Impact factor: 1.475

4.  Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.

Authors:  Ninib Baryawno; Afsar Rahbar; Nina Wolmer-Solberg; Chato Taher; Jenny Odeberg; Anna Darabi; Zahidul Khan; Baldur Sveinbjörnsson; O-M FuskevÅg; Lova Segerström; Magnus Nordenskjöld; Peter Siesjö; Per Kogner; John Inge Johnsen; Cecilia Söderberg-Nauclér
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

Review 5.  Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

Authors:  Cecilia Söderberg-Nauclér; John Inge Johnsen
Journal:  World J Exp Med       Date:  2015-02-20

6.  Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.

Authors:  N Fustino; D Rakheja; C S Ateek; J C Neumann; J F Amatruda
Journal:  Int J Androl       Date:  2011-06-22

Review 7.  The rationale for targeted therapies in medulloblastoma.

Authors:  Tobey J MacDonald; Dolly Aguilera; Robert C Castellino
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 8.  Is human cytomegalovirus a target in cancer therapy?

Authors:  John Inge Johnsen; Ninib Baryawno; Cecilia Söderberg-Nauclér
Journal:  Oncotarget       Date:  2011-12

9.  Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis.

Authors:  Jeannine Lacroix; Franziska Schlund; Barbara Leuchs; Kathrin Adolph; Dominik Sturm; Sebastian Bender; Thomas Hielscher; Stefan M Pfister; Olaf Witt; Jean Rommelaere; Jörg R Schlehofer; Hendrik Witt
Journal:  Int J Cancer       Date:  2013-09-02       Impact factor: 7.396

Review 10.  Pediatric medulloblastoma - update on molecular classification driving targeted therapies.

Authors:  Ruth-Mary DeSouza; Benjamin R T Jones; Stephen P Lowis; Kathreena M Kurian
Journal:  Front Oncol       Date:  2014-07-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.